Plasmablastic Lymphoma — Trials

Plasmablastic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

18 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01961063	Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma	active not recruiting	Phase 1	3	City of Hope Medical CenterOTHER	1	Sep 1, 2026	clinicaltrials
NCT02797470	Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant	active not recruiting	Phase 1 / Phase 2	11	AIDS Malignancy ConsortiumNETWORK	1	May 18, 2026	clinicaltrials